%0 Journal Article
%T Reference pricing systems in Europe: characteristics and consequences
%A Pieter Dylst
%A PharmD
%A Professor Steven Simoens
%A MSc
%A PhD
%A Professor Arnold G Vulto
%A PharmD
%A PhD
%J Generics and Biosimilars Initiative Journal
%D 2012
%I Pro Pharma Communications International
%X Introduction: A reference pricing system is a system that establishes a common reimbursement level or reference price for a group of interchangeable medicines, i.e. the reference group. This article provides an overview of the different characteristics of the different reference pricing systems in Europe. Additionally, the impact of reference pricing on price competition, generic medicine use, pharmaceutical expenditure and health outcome will be discussed.Methods: Studies relevant for this article were found by means of a literature review. A survey was carried out to document the current status of reference pricing systems in Europe. Survey data were collected from member associations of the European Generic medicines Association in the context of their 2011 survey of European drug retail markets.Results: Many European governments have introduced reference pricing systems. Reference pricing systems reduce medicine prices but not always below the reference price, increase the use of medicines priced at or below the reference price, generate savings in pharmaceutical expenditure that tend to be limited to the short term, and do not seem to adversely affect health outcomes.Conclusion: Reference pricing is a popular policy for governments to contain pharmaceutical expenditures and seems to be effective in the different European countries.
%K Europe
%K generic drugs
%K reference pricing system
%K reimbursement
%K review
%U http://gabi-journal.net/reference-pricing-systems-in-europe-characteristics-and-consequences.html